715 results on '"Scheller, Bruno"'
Search Results
202. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
203. Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial
204. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
205. CD14++CD16+ Monocytes Independently Predict Cardiovascular Events
206. TCT-211 Ambulatory blood pressure and dipping-pattern after catheter-based renal sympathetic denervation in patients with resistant hypertension
207. SeQuent Please World Wide Registry
208. TCT-13 Renal resistive indices, urinary albumin excretion and renal function in patients with resistant hypertension after catheter-based renal sympathetic denervation
209. Drug-Coated Balloons — The New Gold Standard for Treatment of Coronary In-Stent Restenosis?
210. Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study
211. Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension
212. Do Pharmacokinetics Explain Persistent Restenosis Inhibition by a Single Dose of Paclitaxel?
213. Drug Coated Balloons in Acute Coronary Syndromes - Opportunities and Limitations
214. PERSISTENCE OF PACLITAXEL IN THE VESSEL WALL AFTER SHORT TIME LOCAL DRUG DELIVERY BY COATED BALLOONS
215. SEQUENT PLEASE WORL WIDE REGISTRY: RESULTS OF PACLITAXEL COATED BALLOON ANGIOPLASTY FOR TREATMENT OF DE-NOVO CORONARY ARTERY DISEASE
216. COMPASSIONATE USE OF A PACLITAXEL COATED BALLOON CATHETER IN PATIENTS WITH REFRACTORY CORONARY IN-STENT RESTENOSIS
217. TIMING OF ANGIOGRAPHY AND CLINICAL OUTCOMES AFTER FIBRINOLYSIS: A PATIENT-LEVEL ANALYSIS OF RANDOMIZED EARLY INVASIVE CLINICAL TRIALS
218. INFLUENCE OF PACLITAXEL DOSE ON A NOVEL COATED SCORING BALLOON CATHETER ON EFFICACY IN PORCINE CORONARY ARTERIES
219. ABSENCE OF DOWNSTREAM MYOCARDIAL EFFECTS AFTER TREATMENT OF PORCINE CORONARY ARTERIES WITH A NOVEL PACLITAXEL COATED SCORING BALLOON CATHETER
220. SEQUENT PLEASE WORLD WIDE REGISTRY: EFFICACY OF PACLITAXEL COATED BALLOON ANGIOPLASTY FOR TREATMENT OF DRUG-ELUTING STENT RESTENOSIS COMPARED WITH BARE-METAL STENT RESTENOSIS
221. Thrombus aspiration in non-ST-elevation myocardial infarction – 12-month clinical outcome of the randomised TATORT-NSTEMI trial
222. Long-Term Follow-Up of Early Versus Delayed Invasive Approach After Fibrinolysis in Acute Myocardial Infarction
223. Drug-eluting balloons: where are we and what are the problems?
224. New technologies in percutaneous coronary interventions: drug-coated balloons
225. Paclitaxel-eluting balloon plus a bare metal stent vs. sirolimus-eluting stent: IVUS insights in the PEPCAD-III multicenter trial
226. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells
227. From bench to Paccocath
228. PCI in small vessels: the case for a drug-coated balloon based intervention
229. How to use the drug-eluting balloon: recommendations by the German consensus group
230. Local drug delivery – the early Berlin experience: single drug administration versus sustained release
231. Dose Response to Paclitaxel-Coated Balloon Catheters in the Porcine Coronary Overstretch and Stent Implantation Model
232. SUCCESSFUL INHIBITION OF CORONARY NEO-INTIMAL HYPERPLASIA IN SWINE USING A NOVEL PACLITAXEL-COATED SCORING BALLOON CATHETER
233. Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI!
234. Interventionelle Behandlung der malignen Hypertonie – Pathophysiologie und klinische Daten
235. Response to Letter Regarding Article, “Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis”
236. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter
237. Simultaneous measurement of cardiac perfusion and permeability in vivo with Synchrotron radiation imaging
238. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis
239. Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis
240. Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease
241. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model
242. Drug-eluting balloon: Very short-term exposure and overlapping
243. Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions.
244. Abstract 5258: SDF1-Triggered Erk-2 Activation In Endothelial Progenitor Cells In Patients With Coronary Artery Disease And Healthy Controls: Role For Adhesion And Migration
245. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
246. Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago
247. Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg
248. Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model
249. Aktuelle Kardiologie 2006/2007
250. Reduction of Stenosis Due to Intimal Hyperplasia After Stent Supported Angioplasty of Peripheral Arteries by Local Administration of Paclitaxel in Swine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.